期刊文献+

夫西地酸对葡萄球菌的抗生素后效应的研究

In vitro antibacterial effects of fusidic acid against Staphylococcus spp
下载PDF
导出
摘要 目的 研究夫西地酸对临床分离的葡萄球菌的体外抗菌作用,为夫西地酸的临床合理应用提供依据.方法 采用琼脂二倍稀释法测定夫西地酸的最低抑菌浓度(MIC),以夫西地酸的MIC为基础,根据抗生素后效应理论,应用光密度法测定了夫西地酸对1株ATCC 29213、2株表面葡萄球菌和4株金黄色葡萄球菌(包括2株耐甲氧西林的金黄色葡萄球菌和2株甲氧西林敏感的金黄色葡萄球菌)的体外PAE.结果 87.7%的葡萄球菌对夫西地酸敏感,耐药菌主要为耐甲氧西林的凝固酶阴性葡萄球菌;夫西地酸对上述7株葡萄球菌的抗生素后效应(PAE)的范围为0.14~1.54 h.结论 夫西地酸对各种葡萄球菌,包括耐甲氧西林的金葡菌具有良好的抗菌作用;夫西地酸对葡萄球菌具有较短的PAE,且随药物浓度的不同,PAE也不一样. Objective To investigate the vitro antibacterial effects of fusidic acid against Staphylococcus spp. Methods The MICs of fusidic acid agents were determined by the standard two-fold agar dilution method. According to the MIC of fusidic acid and the theory of MIC, the invitro post antibiotic effect of fusidic against ATCC29213, 2 strains of Staphylococcus epidermidis and 4 strains of Staphylococcus aureus(two strains of MRSA and two strains of MSSA) were determined by means of measurement of transmittance using BIO-RAD SmartSpec plus. Results 87.7% strains of Staphylococcus spp. were susceptible to fusidic acid and majority of the resistant strains were coagulase negative isolates, the MIC range for the seven S. aureus strains for fusidic acid was 0. 14 - 1.54h. Conclusions Fusidic acid is an effective antibacterial agent against methicillin resistant and methicillin sus- ceptible Staphylococcus spp ;fusidic acid had a small post antibiotic influence against Staphylococcus spp. The PAE were different with the difference of concentration.
出处 《四川医学》 CAS 2013年第10期1549-1551,共3页 Sichuan Medical Journal
关键词 夫西地酸 最低抑菌浓度 抗生素后效应 葡萄球菌 fusidic acid MIC PAE staphylococcus spp
  • 相关文献

参考文献6

二级参考文献54

  • 1陈莉延,梁标.夫西地酸治疗社区获得性革兰阳性球菌性肺炎[J].广东医学,2006,27(2):275-276. 被引量:3
  • 2张永信.抗菌药物新品种临床评价[J].世界临床药物,2006,27(9):532-536. 被引量:2
  • 3朱红燕,唐志刚.夫西地酸的抗菌药理与临床应用[J].交通医学,2007,21(2):211-212. 被引量:18
  • 4戚佳叶,王林.耐甲氧西林葡萄球菌耐药形势和治疗药物[J].中国高等医学教育,2007(7):94-95. 被引量:1
  • 5[1]Verbist L. The antimicrobial activity of fusidic acid[J ]. J Antimicrob Chemother, 1990, 25 (Suppl B): 1 -5.
  • 6[2]Protier H. A multicentre, open, clinical trail of a new intravenous formulation of fusidic acid in severe Staphylococcal infections[J ].J Antimicrob Chemother, 1990, 25(Suppl B): 39- 44.
  • 7[3]Menday AP. MarshBT. Intravenous fusidic acid (Fucidin) inthe managarnent of severe Staphylococcal infections: a review of 46 cases[J]. Curr Med Res Opin, 1976, 4:132 - 138.
  • 8[4]Whitby M. Fusidic acid in septicemia and endocarditis[J]. Int. J Antimicrob Agents, 1999, 12(2): 17-22.
  • 9[5]Jensen K, Lassen HC. Combined treatment with antibacterial chemotherapeutical agents in Staphylococcal infections[J ]. Q J Med, 1969, 38: 91-106.
  • 10[6]Coombs RR, Menday AP. Fusidic acid in Staphylococcal infections due to coagulase-negative Staphylococci [J ]. Curr Med Res Opin, 1985b, 9: 587-590.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部